×
AI drives bull market momentum, says Truist investment chief
Written by
Published on
Join our daily newsletter for breaking news, product launches and deals, research breakdowns, and other industry-leading AI coverage
Join Now

AI dominance has emerged as the defining characteristic of the current bull market, according to Keith Lerner, co-chief investment officer at Truist Wealth, a major financial services firm. Speaking on CNBC’s “Closing Bell,” Lerner highlighted how artificial intelligence continues to drive market sentiment and investment flows, reinforcing the technology sector’s outsized influence on broader market performance.

What you should know: The discussion took place during CNBC’s market wrap-up show, featuring insights from two prominent investment strategists analyzing daily market movements and future outlook.

Who was involved: The segment included Stephanie Link, chief investment strategist at Hightower Advisors, alongside Lerner providing their perspectives on market conditions.

  • Both strategists offered commentary on the day’s trading activity and shared their broader investment outlook with viewers.

The big picture: AI’s role as the bull market‘s central theme reflects the technology’s continued ability to capture investor attention and drive significant capital allocation decisions.

  • This observation comes as markets continue to respond to developments in artificial intelligence across various sectors and applications.

Why this matters: Understanding AI’s market influence helps investors and analysts gauge the sustainability of current market trends and identify potential areas of concentration risk or opportunity.

Bull market's dominant theme is AI, says Truist Wealth co-CIO

Recent News

C3 AI shares plummet 30% as CEO health issues impact sales

Siebel's autoimmune disease caused "significant visual impairment" and reduced his sales involvement.

Micron raises Q4 forecast to $11.2B on surging AI memory chip demand

Memory chips have become the backbone of intensive AI data-processing workloads.

Biotech startup Tahoe raises $30M for AI cancer drug discovery platform

The company's Mosaic platform generates massive single-cell datasets to train virtual cell models.